SCHEMBL383329

SCHEMBL383329

NC(=O)c1ccc(N2CCC(Nc3ncccn3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 7/20 0.51
▸ DRD3 P35462 7/20 0.51
▸ CNR1 P21554 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ JAK2 O60674 2/20 0.47
▸ SYK P43405 5/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.45
▸ GPR119 Q8TDV5 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ FLT3 P36888 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL383016 0.88 DRD2 (0.55) DRD2DRD3CNR1CNR2MAPK1
SCHEMBL383328 0.87 DRD2 (0.51) DRD2DRD3SYKMAPK1NPC1
SCHEMBL382510 0.81 NOS2 (0.51) DRD2DRD3MAPK1
SCHEMBL382583 0.81 CASR (0.54) DRD2DRD3CNR1CNR2
SCHEMBL383181 0.81 CASR (0.54) DRD2DRD3CNR1CNR2
SCHEMBL382964 0.79 CASR (0.45) DRD2DRD3
SCHEMBL28747046 0.79 ITGB3 (0.49) DRD2DRD3CNR1CNR2
SCHEMBL7539445 0.79 CNR1 (0.44) DRD2DRD3CNR1CNR2
SCHEMBL382962 0.79 ITGB3 (0.49) DRD2DRD3CNR1CNR2
SCHEMBL382518 0.78 DRD2 (0.53) DRD2DRD3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 — — EP claimed
CN-1303377-A Amino piperidine derivatives as integrin alpha beta 3 antagonists MEIJI SEIKA KAISHA (JP) 2001-07-11 — — CN claimed
CN-1303377-A Amino piperidine derivatives as integrin alpha beta 3 antagonists MEIJI SEIKA KAISHA (JP) 2001-07-11 — — CN disclosed
Send feedback